Impact of Surgery on Quality of Life in Patients with Hepatocellular Carcinoma

被引:21
|
作者
Mise, Yoshihiro [1 ]
Satou, Shouichi [1 ]
Ishizawa, Takeaki [1 ]
Kaneko, Junichi [1 ]
Aoki, Taku [1 ]
Hasegawa, Kiyoshi [1 ]
Sugawara, Yasuhiko [1 ]
Makuuchi, Masatoshi [2 ]
Kokudo, Norihiro [1 ]
机构
[1] Univ Tokyo, Hepatobiliary Pancreat Surg Div, Dept Surg, Grad Sch Med,Bunkyo Ku, Tokyo 1138655, Japan
[2] Japanese Red Cross Med Ctr, Dept Hepatobiliary Pancreat Surg, Tokyo, Japan
关键词
SF-36 HEALTH SURVEY; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; HEPATIC RESECTION; RADIOFREQUENCY ABLATION; LIVER RESECTION; GENDER-DIFFERENCES; REPEAT HEPATECTOMY; SURGICAL RESECTION; CANCER; DISEASE;
D O I
10.1007/s00268-013-2342-9
中图分类号
R61 [外科手术学];
学科分类号
摘要
Liver resection is the mainstay of curative treatment for localized hepatocellular carcinoma (HCC). However, the impact of surgery for HCC on quality of life (QOL) has not been well assessed. Health-related QOL was assessed using the Short Form-36 questionnaire in 108 patients who underwent a liver resection for HCC between January 2004 and January 2008. The QOL assessment was scheduled before and every 3 months after the operation. Patients were divided into two groups based on patient-, tumor-, and surgery-related variables. The physical component summary (PCS) and mental component summary (MCS) were compared between the two groups. Altogether, 69 patients (64 %) completed the consecutive QOL assessments until 6 months after surgery. At 3 months, the PCS scores were significantly lower for women and for patients who had undergone thoracotomy than among men (p = 0.010) and patients who had not undergone thoracotomy (p = 0.048), respectively. No significant differences in any of the PCS scores were observed at 6 months. No significant differences in the MCS scores were observed between the groups throughout the investigation, and improvement relative to the preoperative status was observed at 6 months. Physical impairments in the QOL after surgery had returned to the baseline at 6 months, and the postoperative mental QOL improved relative to the preoperative state. The surgical candidates were expected to have a satisfactory QOL regardless of the preoperative status and surgical outcomes. A thoracoabdominal approach had a transient negative impact on the physical health status.
引用
收藏
页码:958 / 967
页数:10
相关论文
共 50 条
  • [1] Impact of Surgery on Quality of Life in Patients with Hepatocellular Carcinoma
    Yoshihiro Mise
    Shouichi Satou
    Takeaki Ishizawa
    Junichi Kaneko
    Taku Aoki
    Kiyoshi Hasegawa
    Yasuhiko Sugawara
    Masatoshi Makuuchi
    Norihiro Kokudo
    [J]. World Journal of Surgery, 2014, 38 : 958 - 967
  • [2] QUALITY OF LIFE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Lee, Lukas Jyuhn-Hsiarn
    Chen, Chien-Hung
    Yao, Grace
    Chung, Chih-Wen
    Sheu, Jin-Chuan
    Lee, Po-Huang
    Wang, Jung-Der
    [J]. QUALITY OF LIFE RESEARCH, 2004, 13 (09) : 1503 - 1503
  • [3] Impact of sorafenib on quality of life in hepatocellular carcinoma
    Abraham, A. M.
    Nair, B.
    Anand, A. S.
    Kuriakose, V. G.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 30 - 30
  • [4] Patients' Experience of Systemic Treatment of Hepatocellular Carcinoma: A Review of the Impact on Quality of Life
    Muzellec, Lea
    Bourien, Heloise
    Edeline, Julien
    [J]. CANCERS, 2022, 14 (01)
  • [5] The impact of hepatocellular carcinoma diagnosis on patients' health-related quality of life
    Verma, Manisha
    Paik, James M.
    Younossi, Issah
    Tan, Daisong
    Abdelaal, Hala
    Younossi, Zobair M.
    [J]. CANCER MEDICINE, 2021, 10 (18): : 6273 - 6281
  • [6] Understanding quality of life in patients with hepatocellular carcinoma
    Hudgens, S.
    Copher, R.
    Floden, L.
    Meier, G.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 77 - 77
  • [7] Reduced quality of life of patients with hepatocellular carcinoma
    Bianchi, G
    Loguercio, C
    Sgarbi, D
    Abbiati, R
    Brunetti, N
    De Simone, T
    Zoli, M
    Marchesini, G
    [J]. DIGESTIVE AND LIVER DISEASE, 2003, 35 (01) : 46 - 54
  • [8] DETRIMENTAL IMPACT OF TOXICITY ON QUALITY OF LIFE IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH LENVATINIBOR SORAFENIB
    Hudgens, S.
    Misurski, D.
    Meier, G.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A411 - A412
  • [9] Fear of Progression and Quality of Life in Patients with Hepatocellular Carcinoma
    Li, In Fun
    Tasy, Shiow-Luan
    Bair, Ming Jong
    Wang, Tsang-En
    [J]. PSYCHO-ONCOLOGY, 2015, 24 : 267 - 268
  • [10] Understanding quality of life in hepatocellular carcinoma patients.
    Hudgens, Stacie
    Copher, Ronda
    Floden, Lysbeth
    Meier, Genevieve
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)